Cargando…

New approaches for detecting cancer with circulating cell-free DNA

Detalles Bibliográficos
Autores principales:	Fiala, Clare, Diamandis, Eleftherios P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6696683/ https://www.ncbi.nlm.nih.gov/pubmed/31416458 http://dx.doi.org/10.1186/s12916-019-1400-z

Ejemplares similares

Circulating tumor DNA for personalized lung cancer monitoring
por: Fiala, Clare, et al.
Publicado: (2017)

Utility of circulating tumor DNA in cancer diagnostics with emphasis on early detection
por: Fiala, Clare, et al.
Publicado: (2018)

Can circulating tumor DNA be used for direct and early stage cancer detection?
por: Diamandis, Eleftherios P, et al.
Publicado: (2017)

Can Circulating Tumor DNA Support a Successful Screening Test for Early Cancer Detection? The Grail Paradigm
por: Pons-Belda, Oscar D., et al.
Publicado: (2021)

Genomic profiling for copy number changes in plasma of ovarian cancer patients – a new era for cancer diagnostics?
por: Kulasingam, Vathany, et al.
Publicado: (2016)

The democratization of scientific publishing
por: Fiala, Clare, et al.
Publicado: (2019)

Make researchers revisit past publications to improve reproducibility
por: Fiala, Clare, et al.
Publicado: (2017)

Mutations in normal tissues—some diagnostic and clinical implications
por: Fiala, Clare, et al.
Publicado: (2020)

The failure of protein cancer biomarkers to reach the clinic: why, and what can be done to address the problem?
por: Diamandis, Eleftherios P
Publicado: (2012)

The hundred person wellness project and Google’s baseline study: medical revolution or unnecessary and potentially harmful over-testing?
por: Diamandis, Eleftherios P
Publicado: (2015)

My scientific genealogy and the Toronto ACDC Laboratory, 1988–2022
por: Diamandis, Eleftherios P.
Publicado: (2022)

TP53 mutations on circulating cell-free DNA
por: Pantel, Klaus
Publicado: (2016)

ALK Fusion Detection in Circulating Free DNA: Finding an Important Needle in the Haystack
por: Mooradian, Meghan J., et al.
Publicado: (2017)

Fascin-1 is a novel biomarker of aggressiveness in some carcinomas
por: Kulasingam, Vathany, et al.
Publicado: (2013)

Multi Cancer Early Detection by Using Circulating Tumor DNA—The Galleri Test. Reply to Klein et al. The Promise of Multicancer Early Detection. Comment on “Pons-Belda et al. Can Circulating Tumor DNA Support a Successful Screening Test for Early Cancer Detection? The Grail Paradigm. Diagnostics 2021, 11, 2171”
por: Pons-Belda, Oscar D., et al.
Publicado: (2022)

DNA methylation signatures in circulating cell-free DNA for the monitoring of at-risk populations progressing to lung cancer
por: Tost, Jörg
Publicado: (2015)

The struggle to detect circulating DNA
por: Zeerleder, Sacha
Publicado: (2006)

Protect Your Fibroblasts Before They Become Gametes
por: Fernandez-Uriarte, Amaia, et al.
Publicado: (2022)

Diagnostic potential of circulating cell-free DNA in patients needing mechanical ventilation: promises and challenges
por: Arnalich, Francisco, et al.
Publicado: (2011)

Circulating cell-free DNA for cancer early detection
por: Gao, Qiang, et al.
Publicado: (2022)

The potential of combined mutation sequencing of plasma circulating cell‐free DNA and matched white blood cells for treatment response prediction
por: van der Leest, Paul, et al.
Publicado: (2020)

Towards a more sensitive detection of somatic mutations in cell-free DNA
por: Earl, Julie
Publicado: (2019)

Cell-free DNA and outcome in sepsis
por: Rhodes, Andrew, et al.
Publicado: (2012)

Circulating testosterone and prostate-specific antigen in nipple aspirate fluid and tissue are associated with breast cancer.
por: Sauter, Edward R, et al.
Publicado: (2002)

Consumer-grade electroencephalography devices as potential tools for early detection of brain tumors
por: Samuel, Nardin, et al.
Publicado: (2021)

Circulating Tumor DNA: A Potential Novel Diagnostic Approach in Gestational Trophoblastic Neoplasia
por: Bolze, Pierre-Adrien, et al.
Publicado: (2016)

The detection of donor-derived cell-free DNA may serve as a biomarker for the early detection of chronic lung allograft dysfunction
por: Bansal, Sandhya, et al.
Publicado: (2019)

Circulating Cell-Free Tumour DNA for Early Detection of Pancreatic Cancer
por: Jaworski, Jedrzej J., et al.
Publicado: (2020)

Lung Cancer Early Detection: The Role of Circulating MicroRNAs
por: Bianchi, Fabrizio
Publicado: (2015)

Somatic copy number aberrations detected in circulating tumor DNA can hold diagnostic value for early detection of hepatocellular carcinoma
por: Chatzaki, Ekaterini, et al.
Publicado: (2020)

A DNA Methylation-Based Test for Breast Cancer Detection in Circulating Cell-Free DNA
por: Salta, Sofia, et al.
Publicado: (2018)

Simultaneous Discovery of Cell-Free DNA and the Nucleosome Ladder
por: Henikoff, Steven, et al.
Publicado: (2018)

A new enzyme-linked immunosorbent assay (ELISA) for human free and bound kallikrein 9
por: Filippou, Panagiota, et al.
Publicado: (2017)

Towards identification of true cancer biomarkers
por: Diamandis, Eleftherios P
Publicado: (2014)

Cell-free circulating tumor DNA in cancer
por: Qin, Zhen, et al.
Publicado: (2016)

Detection of Cell Types Contributing to Cancer From Circulating, Cell-Free Methylated DNA
por: Barefoot, Megan E., et al.
Publicado: (2021)

Plasma cell‐free DNA analysis for COVID‐19 and beyond
por: Ju, Jia, et al.
Publicado: (2022)

Circulating cell-free nucleic acids as potential biomarkers for sarcopenia: a step toward personalized medicine
por: Shafiee, Gita, et al.
Publicado: (2017)

Circulating Cell-Free DNA or Circulating Tumor DNA in the Management of Ovarian and Endometrial Cancer
por: Chen, Qian, et al.
Publicado: (2019)

Circulating tumor DNA based minimal residual disease detection and adjuvant treatment decision-making for muscle-invasive bladder cancer guided by modern clinical trials
por: Nawaf, Cayce, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qnncqe7dg17htapufv0gi359f0